vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and RADIANT LOGISTICS, INC (RLGT). Click either name above to swap in a different company.
RADIANT LOGISTICS, INC is the larger business by last-quarter revenue ($232.1M vs $207.8M, roughly 1.1× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 2.3%, a 55.1% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $11.6M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Radiant Logistics, Inc. is a leading third-party logistics provider offering end-to-end supply chain solutions, domestic and international freight forwarding, warehousing, and last-mile delivery services. It primarily serves North American markets, with key client segments including retail, manufacturing, e-commerce, and industrial sectors, helping businesses optimize logistics workflows and cut operational costs.
IDYA vs RLGT — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $207.8M | $232.1M |
| Net Profit | $119.2M | $5.3M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 3.2% |
| Net Margin | 57.4% | 2.3% |
| Revenue YoY | — | -12.3% |
| Net Profit YoY | 330.1% | -18.0% |
| EPS (diluted) | $1.33 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $232.1M | ||
| Q3 25 | $207.8M | $226.7M | ||
| Q2 25 | — | $220.6M | ||
| Q1 25 | — | $214.0M | ||
| Q4 24 | — | $264.5M | ||
| Q3 24 | $0 | $203.6M | ||
| Q2 24 | $0 | $206.0M | ||
| Q1 24 | $0 | $184.6M |
| Q4 25 | — | $5.3M | ||
| Q3 25 | $119.2M | $1.3M | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | — | $2.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $-51.8M | $3.4M | ||
| Q2 24 | $-52.8M | $4.8M | ||
| Q1 24 | $-39.6M | $-703.0K |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 52.2% | 0.9% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | -0.5% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | 57.4% | 0.6% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -0.4% |
| Q4 25 | — | $0.11 | ||
| Q3 25 | $1.33 | $0.03 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $0.13 | ||
| Q3 24 | $-0.60 | $0.07 | ||
| Q2 24 | $-0.68 | $0.11 | ||
| Q1 24 | $-0.53 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $31.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $229.8M |
| Total Assets | $1.2B | $439.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $31.9M | ||
| Q3 25 | $786.9M | $28.1M | ||
| Q2 25 | — | $22.9M | ||
| Q1 25 | — | $19.0M | ||
| Q4 24 | — | $19.9M | ||
| Q3 24 | $920.0M | $10.4M | ||
| Q2 24 | $701.7M | $24.9M | ||
| Q1 24 | $698.8M | $31.2M |
| Q4 25 | — | $229.8M | ||
| Q3 25 | $1.1B | $225.7M | ||
| Q2 25 | — | $226.0M | ||
| Q1 25 | — | $218.2M | ||
| Q4 24 | — | $214.4M | ||
| Q3 24 | $1.2B | $212.4M | ||
| Q2 24 | $931.7M | $209.4M | ||
| Q1 24 | $935.3M | $206.0M |
| Q4 25 | — | $439.4M | ||
| Q3 25 | $1.2B | $445.3M | ||
| Q2 25 | — | $426.8M | ||
| Q1 25 | — | $414.5M | ||
| Q4 24 | — | $386.8M | ||
| Q3 24 | $1.2B | $375.3M | ||
| Q2 24 | $973.7M | $371.2M | ||
| Q1 24 | $961.5M | $364.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $12.4M |
| Free Cash FlowOCF − Capex | $142.2M | $11.6M |
| FCF MarginFCF / Revenue | 68.4% | 5.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.19× | 2.33× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $8.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $12.4M | ||
| Q3 25 | $142.2M | $2.5M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | — | $-5.7M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | $-49.2M | $205.0K | ||
| Q2 24 | $-32.9M | $1.3M | ||
| Q1 24 | $-43.8M | $3.9M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | $142.2M | $977.0K | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $-6.4M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | $-49.7M | $-1.9M | ||
| Q2 24 | $-33.9M | $-185.0K | ||
| Q1 24 | $-45.1M | $1.8M |
| Q4 25 | — | 5.0% | ||
| Q3 25 | 68.4% | 0.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | — | -0.9% | ||
| Q2 24 | — | -0.1% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.2% |
| Q4 25 | — | 2.33× | ||
| Q3 25 | 1.19× | 1.90× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | -2.26× | ||
| Q4 24 | — | 2.43× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.26× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
RLGT
| Transferred Over Time | $201.2M | 87% |
| Other | $25.0M | 11% |
| Value Added Services | $4.2M | 2% |
| Transferred At Point In Time | $1.8M | 1% |